CHROChromocell Therapeutics Corp

NYSE chromocell.com


$ 2.03 $ -0.06 (-2.76 %)    

Wednesday, 15-May-2024 11:21:24 EDT
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 2.11
$ 2.25
$ 0.00 x 0
$ 0.00 x 0
$ 2.03 - $ 2.25
$ 1.21 - $ 6.00
22,010
na
12.17M
$ 1.93
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-16-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-travelers-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.

 why-invo-bioscience-shares-are-trading-higher-by-around-73-here-are-20-stocks-moving-premarket

Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results.

Core News & Articles

Dear Fellow Stockholders,With my inaugural letter to stockholders, I am pleased to provide an update on our recent initial publ...

Core News & Articles

Chromocell Therapeutics Corp. ("Chromocell", or the "Company"), (NYSE:CHRO), a pioneer in the development of no...

Core News & Articles

Benuvia Operations, LLC ("Benuvia"), a leader in pharmaceutical innovation, and Chromocell Therapeutics Corp. ("Chr...

Core News & Articles

Chromocell Therapeutics Corporation (NYSE:CHRO) ("Chromocell" or the "Company"), a clinical-stage biotech compa...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION